Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IPIX | US
-0.00
-70.00%
Healthcare
Biotechnology
30/09/2023
24/04/2026
0.00
0.00
0.00
0.00
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
2183.5%1 month
1643.6%3 months
1688.7%6 months
1247.9%-
-
0.45
0.20
0.04
-1.08
202.69
-
-1.99M
155.50K
155.50K
-
-
-
-
-114.34
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.01
Range1M
0.01
Range3M
0.02
Rel. volume
0.04
Price X volume
1.78
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Windtree Therapeutics Inc | WINT | Biotechnology | 0.0224 | 82.42K | 1.82% | n/a | 36.99% |
| Syros Pharmaceuticals Inc | SYRS | Biotechnology | 0.0002 | 5.36K | -33.33% | n/a | -954.99% |
| Calithera Biosciences Inc | CALA | Biotechnology | 0.0003 | 1.46K | 200.00% | n/a | 8.17% |
| XOMAP | XOMAP | Biotechnology | 26.125 | 0 | 26.27 | 121.93% | |
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.4278 | 0 | -0.44% | 25.57 | 121.93% |
| Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0 | 0 | -100.00% | n/a | 113.12% |
| SABSW | SABSW | Biotechnology | 0.0185 | 0 | 0.17 | 11.58% | |
| Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 4.43 | 0 | 3.02% | n/a | 5.40% |
| REVBW | REVBW | Biotechnology | 0.0092 | 0 | n/a | 0.00% | |
| Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.17 | 0 | -2.50% | n/a | 1.72% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.08 | 0.53 | Cheaper |
| Ent. to Revenue | 202.69 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.45 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 1,688.73 | 72.80 | Riskier |
| Debt to Equity | 0.20 | -1.23 | Expensive |
| Debt to Assets | 0.04 | 0.25 | Cheaper |
| Market Cap | 155.50K | 3.66B | Emerging |